Search by Drug Name or NDC

    NDC 59148-0030-85 Abilify MyCite 5 mg/1 Details

    Abilify MyCite 5 mg/1

    Abilify MyCite is a ORAL TABLET WITH SENSOR in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is ARIPIPRAZOLE.

    Product Information

    NDC 59148-0030
    Product ID 59148-030_e9560dde-6499-413d-abc5-9f4b5ed8504f
    Associated GPIs 59250015000367 59250015000368 59250015000365
    GCN Sequence Number 082066
    GCN Sequence Number Description aripiprazole TABSENSTPD 5 MG ORAL
    HIC3 H7X
    HIC3 Description ANTIPSYCHOTICS, ATYP, D2 PARTIAL AGONIST/5HT MIXED
    GCN 49366
    HICL Sequence Number 024551
    HICL Sequence Number Description ARIPIPRAZOLE
    Brand/Generic Brand
    Proprietary Name Abilify MyCite
    Proprietary Name Suffix n/a
    Non-Proprietary Name ARIPIPRAZOLE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET WITH SENSOR
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name ARIPIPRAZOLE
    Labeler Name Otsuka America Pharmaceutical, Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207202
    Listing Certified Through 2024-12-31

    Package

    NDC 59148-0030-85 (59148003085)

    NDC Package Code 59148-030-85
    Billing NDC 59148003085
    Package 1 BOTTLE in 1 KIT (59148-030-85) / 30 TABLET WITH SENSOR in 1 BOTTLE (59148-030-13)
    Marketing Start Date 2018-01-31
    NDC Exclude Flag N
    Pricing Information N/A